Search

Author/Creator Ferree, Sean

3. Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study. Issue 2 (10th January 2021)

Authors:
Buus, Richard; Sestak, Ivana; Kronenwett, Ralf; Ferree, Sean; Schnabel, Catherine A.; Baehner, Frederick L.; Mallon, Elizabeth A.; Cuzick, Jack; Dowsett, Mitch
Journal:
Journal of clinical oncology
Issue:
Volume 39:Issue 2(2021)
Page Start:
126
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Prospective study of the impact of the Prosigna assay on adjuvant clinical decision-making in unselected patients with estrogen receptor positive, human epidermal growth factor receptor negative, node negative early-stage breast cancer. (23rd April 2015)

Authors:
Martín, Miguel; González-Rivera, Milagros; Morales, Serafín; de la Haba-Rodriguez, Juan; González-Cortijo, Lucía; Manso, Luis; Albanell, Joan; González-Martín, Antonio; González, Sónia; Arcusa, Angels; de la Cruz-Merino, Luis; Rojo, Federico; Vidal, María; Galván, Patricia; Aguirre, Elena; Morale...
Journal:
Current medical research and opinion
Issue:
Volume 31:Number 6(2015:Jun.)
Page Start:
1129
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. The ability of PAM50 risk of recurrence score to predict 10-year distant recurrence in hormone receptor-positive postmenopausal women with special histological subtypes. (2nd January 2018)

Authors:
Laenkholm, Anne-Vibeke; Jensen, Maj-Britt; Eriksen, Jens Ole; Buckingham, Wesley; Ferree, Sean; Nielsen, Torsten O.; Ejlertsen, Bent
Journal:
Acta oncologica
Issue:
Volume 57:Number 1(2018)
Page Start:
44
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗